Curcumin and Omega-3 Fatty Acids Enhance NK Cell-induced Apoptosis of Pancreatic Cancer Cells but Curcumin Inhibits Interferon-γ Production: Benefits of Omega-3 with Curcumin Against Cancer

Overview

Journal Molecules

Publisher MDPI

Specialty Biology

Date 2015 Feb 17

PMID 25685909

Citations 18

Authors

Milan Fiala

Affiliations

Soon will be listed here.

Abstract

STAT-3 and STAT-1 signaling have opposite effects in oncogenesis with STAT-3 acting as an oncogene and STAT-1 exerting anti-oncogenic activities through interferon-γ and interferon-α. The cytokine IL-6 promotes oncogenesis by stimulation of NFκB and STAT-3 signaling. Curcuminoids have bi-functional effects by blocking NFκB anti-apoptotic signaling but also blocking anti-oncogenic STAT-1 signaling and interferon-γ production. In our recent study (unpublished work [1]) in pancreatic cancer cell cultures, curcuminoids enhanced cancer cell apoptosis both directly and by potentiating natural killer (NK) cell cytotoxic function. The cytotoxic effects of curcuminoids were increased by incubation of cancer cells and NK cells in an emulsion with omega-3 fatty acids and antioxidants (Smartfish), which enhanced cancer cell apoptosis and protected NK cells against degradation. However, as also shown by others, curcuminoids blocked interferon-γ production by NK cells. The combined use of curcuminoids and omega-3 in cancer immunotherapy will require deeper understanding of their in vivo interactions with the immune system.

Citing Articles

The Impact of Polyunsaturated Fatty Acids in Cancer and Therapeutic Strategies.

Yan D, Hou Y, Lei X, Xiao H, Zeng Z, Xiong W Curr Nutr Rep. 2025; 14(1):46.

PMID: 40085324 DOI: 10.1007/s13668-025-00639-y.

On the health effects of curcumin and its derivatives.

Ayub H, Islam M, Saeed M, Ahmad H, Al-Asmari F, Ramadan M Food Sci Nutr. 2024; 12(11):8623-8650.

PMID: 39620006 PMC: 11606848. DOI: 10.1002/fsn3.4469.

The Combination of Bioavailable Concentrations of Curcumin and Resveratrol Shapes Immune Responses While Retaining the Ability to Reduce Cancer Cell Survival.

Focaccetti C, Palumbo C, Benvenuto M, Carrano R, Melaiu O, Nardozi D Int J Mol Sci. 2024; 25(1).

PMID: 38203402 PMC: 10779126. DOI: 10.3390/ijms25010232.

Clinical and therapeutical significances of the cluster and signature based on oxidative stress for osteosarcoma.

Ding M, Ran X, Qian S, Zhang Y, Wang Z, Dong M Aging (Albany NY). 2024; 15(24):15360-15381.

PMID: 38180104 PMC: 10781490. DOI: 10.18632/aging.205354.

Phytochemicals as Immunomodulatory Molecules in Cancer Therapeutics.

Paudel S, Mishra N, Agarwal R Pharmaceuticals (Basel). 2023; 16(12).

PMID: 38139779 PMC: 10746110. DOI: 10.3390/ph16121652.

References

Zaidi M, Merlino G . The two faces of interferon-γ in cancer. Clin Cancer Res. 2011; 17(19):6118-24. PMC: 3186825. DOI: 10.1158/1078-0432.CCR-11-0482. View

Xia S, Lu Y, Wang J, He C, Hong S, Serhan C . Melanoma growth is reduced in fat-1 transgenic mice: impact of omega-6/omega-3 essential fatty acids. Proc Natl Acad Sci U S A. 2006; 103(33):12499-504. PMC: 1567907. DOI: 10.1073/pnas.0605394103. View

Dandawate P, Vyas A, Ahmad A, Banerjee S, Deshpande J, Swamy K . Inclusion complex of novel curcumin analogue CDF and β-cyclodextrin (1:2) and its enhanced in vivo anticancer activity against pancreatic cancer. Pharm Res. 2012; 29(7):1775-86. PMC: 3868989. DOI: 10.1007/s11095-012-0700-1. View

Wang W, Edington H, Rao U, Jukic D, Land S, Ferrone S . Modulation of signal transducers and activators of transcription 1 and 3 signaling in melanoma by high-dose IFNalpha2b. Clin Cancer Res. 2007; 13(5):1523-31. DOI: 10.1158/1078-0432.CCR-06-1387. View

Kim K, Ryu K, Ko Y, Park C . Effects of nuclear factor-kappaB inhibitors and its implication on natural killer T-cell lymphoma cells. Br J Haematol. 2005; 131(1):59-66. DOI: 10.1111/j.1365-2141.2005.05720.x. View

Padhye S, Chavan D, Pandey S, Deshpande J, Swamy K, Sarkar F . Perspectives on chemopreventive and therapeutic potential of curcumin analogs in medicinal chemistry. Mini Rev Med Chem. 2010; 10(5):372-87. PMC: 3084451. DOI: 10.2174/138955710791330891. View

Swamy M, Citineni B, Patlolla J, Mohammed A, Zhang Y, Rao C . Prevention and treatment of pancreatic cancer by curcumin in combination with omega-3 fatty acids. Nutr Cancer. 2008; 60 Suppl 1:81-9. DOI: 10.1080/01635580802416703. View

Serhan C, Dalli J, Colas R, Winkler J, Chiang N . Protectins and maresins: New pro-resolving families of mediators in acute inflammation and resolution bioactive metabolome. Biochim Biophys Acta. 2014; 1851(4):397-413. PMC: 4324013. DOI: 10.1016/j.bbalip.2014.08.006. View

Greene E, Huang S, Serhan C, Panigrahy D . Regulation of inflammation in cancer by eicosanoids. Prostaglandins Other Lipid Mediat. 2011; 96(1-4):27-36. PMC: 4051344. DOI: 10.1016/j.prostaglandins.2011.08.004. View

10.

Dhillon N, Aggarwal B, Newman R, Wolff R, Kunnumakkara A, Abbruzzese J . Phase II trial of curcumin in patients with advanced pancreatic cancer. Clin Cancer Res. 2008; 14(14):4491-9. DOI: 10.1158/1078-0432.CCR-08-0024. View

11.

Yu H, Kortylewski M, Pardoll D . Crosstalk between cancer and immune cells: role of STAT3 in the tumour microenvironment. Nat Rev Immunol. 2006; 7(1):41-51. DOI: 10.1038/nri1995. View

12.

Imada K, Bloom E, Nakajima H, Udy G, Davey H, Leonard W . Stat5b is essential for natural killer cell-mediated proliferation and cytolytic activity. J Exp Med. 1998; 188(11):2067-74. PMC: 2212377. DOI: 10.1084/jem.188.11.2067. View

13.

Serhan C, Petasis N . Resolvins and protectins in inflammation resolution. Chem Rev. 2011; 111(10):5922-43. PMC: 3192290. DOI: 10.1021/cr100396c. View

14.

Goel A, Aggarwal B . Curcumin, the golden spice from Indian saffron, is a chemosensitizer and radiosensitizer for tumors and chemoprotector and radioprotector for normal organs. Nutr Cancer. 2010; 62(7):919-30. DOI: 10.1080/01635581.2010.509835. View

15.

Vivier E, Raulet D, Moretta A, Caligiuri M, Zitvogel L, Lanier L . Innate or adaptive immunity? The example of natural killer cells. Science. 2011; 331(6013):44-9. PMC: 3089969. DOI: 10.1126/science.1198687. View

16.

Wei X, Du Z, Zheng X, Cui X, Conney A, Zhang K . Synthesis and evaluation of curcumin-related compounds for anticancer activity. Eur J Med Chem. 2012; 53:235-45. DOI: 10.1016/j.ejmech.2012.04.005. View

17.

Sideras K, Braat H, Kwekkeboom J, van Eijck C, Peppelenbosch M, Sleijfer S . Role of the immune system in pancreatic cancer progression and immune modulating treatment strategies. Cancer Treat Rev. 2013; 40(4):513-22. DOI: 10.1016/j.ctrv.2013.11.005. View

18.

Bill M, Bakan C, Benson Jr D, Fuchs J, Young G, Lesinski G . Curcumin induces proapoptotic effects against human melanoma cells and modulates the cellular response to immunotherapeutic cytokines. Mol Cancer Ther. 2009; 8(9):2726-35. PMC: 2748163. DOI: 10.1158/1535-7163.MCT-09-0377. View

19.

Varalakshmi C, Ali A, Pardhasaradhi B, Srivastava R, Singh S, Khar A . Immunomodulatory effects of curcumin: in-vivo. Int Immunopharmacol. 2008; 8(5):688-700. DOI: 10.1016/j.intimp.2008.01.008. View

20.

Song M, Yim J, Yim J, Kang I, Rho H, Kim H . Use of curcumin to decrease nitric oxide production during the induction of antitumor responses by IL-2. J Immunother. 2011; 34(2):149-64. DOI: 10.1097/CJI.0b013e3182056ec4. View